|
|
| Clopidogrel in a Nutshell |
| |
| |
Markets |
| |
- Clopidogrel, marketed as Plavix, is available as a tablet to reduce the incidence of clot formation associated with cardiovascular surgery and complications
- Clopidogrel is highly insoluble in water, and there are currently no IV or oral liquid dosage forms available
|
| |
Product Advantages |
| |
- With current administration physicians must wait for a number of hours prior to initiating the stenting procedure
- Our injectable formulation has the potential to reach peak blood levels in as little as 30 minutes
|
| |
Development Status |
| |
- Joint development with Prism Pharmaceuticals, Inc.
- Prism to conduct clinical testing and file an NDA
- Prism could file an NDA in early 2010
|
| Updated: May 29, 2008 | |
